ArticleTropical medicine and infectious disease2023
Impact of the COVID-19 Pandemic on Malaria Control in Africa: A Preliminary Analysis.
Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it.
- COVID-19 and malaria co-infection: a systematic review of clinical outcomes in endemic areas.PeerJ · 2024Pooled it
- Geographical Variation in Antimalarial Drug Resistance Marker Prevalence Across the Southern African Elimination Eight Region.medRxiv : the preprint server for health sciences · 2026Article
- Factors influencing the utilisation of malaria preventive services during pregnancy in Ile Ife, Nigeria: a mixed method approach.Malaria journal · 2026Article
- Malaria time series analysis, forecasting, and development of curated intervention strategies for the elimination of malaria from Afghanistan.Malaria journal · 2026Article
- Epidemiological investigation of a possible malaria outbreak in Arba Minch town, Gamo Zone, Southern Ethiopia, 2023.Malaria journal · 2026Article
- A Novel Class of Orally Bioavailable Phenylglycine-Benzoxaborole Conjugates with Antimalarial Activity and Potentially Novel Mechanism of Action.ACS medicinal chemistry letters · 2026Article
- Impact of the COVID-19 pandemic on malaria transmission in the state of Pará, Brazil.Malaria journal · 2025Observational
- Reconsidering rebound malaria: Zanzibari voices on acquired immunity, risk, and history.Malaria journal · 2025Article
- Malaria-Associated Mortality in the 19th Century.The American journal of tropical medicine and hygiene · 2025Article
- Malaria: past, present, and future.Signal transduction and targeted therapy · 2025Review
- Enhanced data quality to improve malaria surveillance in Papua, Indonesia.Malaria journal · 2025Article
- Spatio-temporal modelling and prediction of malaria incidence in Mozambique using climatic indicators from 2001 to 2018.Scientific reports · 2025Article
- Global burden of malaria before and after the COVID-19 pandemic based on the global burden of disease study 2021.Scientific reports · 2025Article
- Evaluating malaria burden in children under-five and intervention outcomes in Tarkwa-Nsuaem municipality.BMC infectious diseases · 2025Article
- A Comprehensive Review: Biology ofInsects · 2025Review
- Effects of vector control interventions on spatio-temporal changes ofFrontiers in public health · 2025Article
- Spatiotemporal prevalence of COVID-19 and SARS-CoV-2 variants in Africa.Frontiers in public health · 2025Article
- Article
- Recent Advancement in Drug Development for Treating Malaria using Herbal Medicine and Nanotechnological Approach.Current pharmaceutical design · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Malaria remains a significant public health concern in Africa, and the emerging coronavirus disease 2019 (COVID-19) pandemic may have negatively impacted malaria control. Here, we conducted a descriptive epidemiological analysis of malaria globally, and preliminarily explored the impact of COVID-19 on the malaria elimination program in regions of Africa (AFR). The present analysis found that there was a vast heterogeneity of incidence of deaths caused by malaria globally in different continents, and the highest malaria burden was observed in AFR. In 2020, there was an obviously increasing trend in the malaria epidemic in AFR, while the other four continents exhibited stable and declining patterns. Historically, malaria has been largely concentrated in high-malaria-burden regions, such as West Africa, and there has been an obvious increasing trend in Nigeria. These data suggest that dynamic changes in the malaria epidemic situation worldwide have primarily originated from AFR, and West Africa has played an important role in the global malaria increase in recent years. Under the coercion of COVID-19, multiple factors have co-driven the increase in malaria in AFR, including insufficient financial investments, a high native malaria burden, weak surveillance systems, limited medical resources, and low socioeconomic development levels. In addition, the shift of medical resources (e.g., health workers and personal protective equipment (PPE), the manufacturing of diagnostic reagents, and drugs) from malaria control to emergency COVID-19 response in the pandemic's early stage caused disruptions, reductions, and delays in pillar malaria control measures, leading to a significant negative impact on malaria control. In particular, a funding shortfall at both the international and domestic levels led to a "significant threat," resulting in vast gaps in access to proven malaria control tools. Although there has been a declining trend in malaria control over time due to COVID-19, the effect still cannot be ignored. Hence, we recommend the implementation of medical and technical resource assistance as a priority strategy to support Africa (West Africa) in order to curb further transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.